Strategies Used by Adults With Diagnosed Diabetes to Reduce Their Prescription Drug Costs, 2017-2018.

08:00 EDT 1st August 2019 | BioPortfolio

Summary of "Strategies Used by Adults With Diagnosed Diabetes to Reduce Their Prescription Drug Costs, 2017-2018."

In 2018, 10.1% of adults aged 18 and over had diagnosed diabetes (1). The majority of those with diabetes take medication for this condition (2). Compared with those without diabetes, adults with diagnosed diabetes experience higher out-of-pocket costs for prescription medications (3) and cost-related, medication nonadherence behaviors (4). Adults have used several strategies to reduce the costs of prescription drugs, including not taking medication as prescribed and asking their doctor for a lower-cost medication (5). This report examines the percentage of adults aged 18 and over with diagnosed diabetes who used these selected strategies to reduce their prescription drug costs.


Journal Details

This article was published in the following journal.

Name: NCHS data brief
ISSN: 1941-4927
Pages: 1-8


DeepDyve research library

PubMed Articles [19081 Associated PubMed Articles listed on BioPortfolio]

Eye Disorders and Vision Loss Among U.S. Adults Aged 45 and Over With Diagnosed Diabetes, 2016-2017.

Diabetes increases with age. In 2017, the prevalence of diagnosed diabetes increased from 13.2% among adults aged 45-64 to 20.1% among those aged 65-74 and 19.8% among those aged 75 and over (1). Comp...

Diabetes and Prediabetes Among Adults in Los Angeles County and the United States, 1999-2006 and 2007-2014.

Objective-This report presents the prevalence of diagnosed diabetes, undiagnosed diabetes, total diabetes, and prediabetes among adults aged 20 and over in Los Angeles County and the United States in ...

Type 2 diabetes prevalence among Canadian adults - dietary habits and sociodemographic risk factors.

Patients with diagnosed diabetes receive recommendations by their healthcare providers about lifestyle modification, particularly on diet. The aim of this study was to determine the prevalence of type...

Symptom Experience of Older Adults With Type 2 Diabetes and Diabetes-Related Distress.

An older, more diverse population and longer life spans are major contributors to the anticipated tripling of Type 2 diabetes prevalence by 2050. Diabetes-related distress affects up to 40% of people ...

Economic costs of implementing group interventions to reduce diabetes distress in adults with type 1 diabetes mellitus in the T1-REDEEM trial.

This study evaluated the implementation costs of two group interventions, one focused on diabetes education (KnowIt) and one focused directly on diabetes distress (OnTrack), that reduced diabetes dist...

Clinical Trials [16196 Associated Clinical Trials listed on BioPortfolio]

Southeastern Diabetes Initiative Clinical Intervention

The purpose of the Southeastern Diabetes Initiative Clinical Intervention is to augment existing standard of care in an effort to (1) improve population level diabetes management, health o...

A Community-based Weight Loss Programme for Chinese Overweight Adults With Pre-diabetes

Type 2 diabetes (T2DM) is a serious chronic condition and one of the world's fastest growing health problems. The onset of T2DM is gradual, with most individuals progressing through a stat...

A Sleep Intervention in Type 1 Diabetes

Insufficient sleep and sleep irregularity (variability in sleep duration) are increasingly recognized as important contributors to glucose control and diabetes distress in type 1 diabetes ...

Effectiveness of a Digital Therapeutic on Type 2 Diabetes

A clinical study evaluating a three month digitally delivered lifestyle change program in adults with Type 2 Diabetes. The FareWell Program (the "Program") aims to reduce well-established ...

A Trial Evaluating Automated Insulin Delivery Technologies on Hypoglycemia and Quality of Life in Older Adults With Type 1 Diabetes

A 28-week crossover study to compare whether closed-loop control (CLC) or predictive low-glucose suspend (PLGS) can reduce hypoglycemia compared with sensor-augmented pump therapy (SAP) in...

Medical and Biotech [MESH] Definitions

Autoimmune diabetes in adults with slowly progressive PANCREATIC BETA CELL failure and the presence of circulating autoantibodies to PANCREATIC ISLETS cell antigens.

Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.

A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Those psychiatric disorders usually first diagnosed in infancy, childhood, or adolescence. These disorders can also be first diagnosed during other life stages.

A condition of abnormally high AMNIOTIC FLUID volume, such as greater than 2,000 ml in the LAST TRIMESTER and usually diagnosed by ultrasonographic criteria (AMNIOTIC FLUID INDEX). It is associated with maternal DIABETES MELLITUS; MULTIPLE PREGNANCY; CHROMOSOMAL DISORDERS; and congenital abnormalities.

Quick Search
DeepDyve research library

Relevant Topic

Prescription Drugs
A prescription drug (also prescription medication or prescription medicine) is a licensed medicine that is regulated by legislation to require a medical prescription before it can be obtained. The term is used to distinguish it from over-the-counter drug...

Searches Linking to this Article